Sterri S H, Lyngaas S, Fonnum F
Acta Pharmacol Toxicol (Copenh). 1980 Jan;46(1):1-7. doi: 10.1111/j.1600-0773.1980.tb02411.x.
Injection of sublethal doses of soman in rat intraperitoneally or subcutaneously every 4, 8, 12 or 24 hours led to chronic LD50 doses which were markedly higher than the acute one. When rats were exposed every 24 hrs to half LD50 doses of soman, several of the animals did not show symptoms of soman poisoning and survived a total exposure of 4-7 times the acute LD50 dose. Brain and diaphragm acetylcholinesterase activities declined steadily during the chronic soman exposure. The so-called external acetylcholinesterase activity of the diaphragm was inhibited to a slightly less degree than the total acetylcholinesterase of the same tissue. The ability of the liver to hydrolyze soman was similar in rats which survived several 24 hr doses and untreated rats.
每4、8、12或24小时给大鼠腹腔内或皮下注射亚致死剂量的梭曼,会导致慢性半数致死剂量显著高于急性半数致死剂量。当大鼠每24小时暴露于半数梭曼半数致死剂量时,一些动物未表现出梭曼中毒症状,并且在总暴露量达到急性半数致死剂量的4至7倍时存活下来。在慢性梭曼暴露期间,脑和膈肌乙酰胆碱酯酶活性稳步下降。膈肌的所谓外周乙酰胆碱酯酶活性受到的抑制程度略低于同一组织的总乙酰胆碱酯酶。在接受多次24小时剂量存活下来的大鼠和未处理的大鼠中,肝脏水解梭曼的能力相似。